Clinical Pharmacokinetics and Pharmacodynamics of Cabozantinib.

Clinical Pharmacokinetics and Pharmacodynamics of Cabozantinib.

Item
http://www.wikidata.org/entity/Q38979283
Cabozantinib in the treatment of hepatocellular carcinoma.Cabozantinib for the treatment of kidney cancer.Cabozantinib in metastatic renal cell carcinoma: latest findings and clinical potential.Practical management of adverse events associated with cabozantinib treatment in patients with renal-cell carcinoma.Assessment of cabozantinib treatment on QT interval in a phase 3 study in medullary thyroid cancer: evaluation of indirect QT effects mediated through treatment-induced changes in serum electrolytes.A whole-animal platform to advance a clinical kinase inhibitor into new disease space.Management of Adverse Events Associated with Cabozantinib Therapy in Renal Cell Carcinoma.A population pharmacokinetic model of cabozantinib in healthy volunteers and patients with various cancer types.Spotlight on cabozantinib for previously untreated advanced renal cell carcinoma: evidence to date
P2860

Clinical Pharmacokinetics and Pharmacodynamics of Cabozantinib.

Item
http://www.wikidata.org/entity/Q38979283
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Clinical Pharmacokinetics and Pharmacodynamics of Cabozantinib.
@en
type
label
Clinical Pharmacokinetics and Pharmacodynamics of Cabozantinib.
@en
prefLabel
Clinical Pharmacokinetics and Pharmacodynamics of Cabozantinib.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P356
P1433
P1476
Clinical Pharmacokinetics and Pharmacodynamics of Cabozantinib.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698